These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 37660994)
1. LINC-PINT suppresses breast cancer cell proliferation and migration via MEIS2/PPP3CC/NF-κB pathway by sponging miR-576-5p. Li D; Hu A Am J Med Sci; 2024 Mar; 367(3):201-211. PubMed ID: 37660994 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA LINC-PINT inhibits non-small cell lung cancer progression through sponging miR-218-5p/PDCD4. Zhang L; Hu J; Li J; Yang Q; Hao M; Bu L Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1595-1602. PubMed ID: 31010333 [TBL] [Abstract][Full Text] [Related]
3. LncRNA LINC-PINT increases SOCS1 expression by sponging miR-155-5p to inhibit the activation of ERK signaling pathway in rheumatoid arthritis synovial fibroblasts induced by TNF-α. Wang J; Zhao Q Int Immunopharmacol; 2020 Jul; 84():106497. PubMed ID: 32289665 [TBL] [Abstract][Full Text] [Related]
4. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer. Hao T; Huang S; Han F Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404 [TBL] [Abstract][Full Text] [Related]
5. [LncRNA LINC-PINT regulating proliferation and apoptosis of osteosarcoma cells by targeting miR-524-5p]. Yang H; Cao C; Wang LJ Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):325-330. PubMed ID: 32375449 [No Abstract] [Full Text] [Related]
6. Linc-PINT acted as a tumor suppressor by sponging miR-543 and miR-576-5p in esophageal cancer. Zhang L; Chen J; Wang L; Chen L; Du Z; Zhu L; Cui M; Zhang M; Song L J Cell Biochem; 2019 Dec; 120(12):19345-19357. PubMed ID: 31464068 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA LINC-PINT retards the abnormal growth of airway smooth muscle cells via regulating the microRNA-26a-5p/PTEN axis in asthma. Gao P; Ding Y; Yin B; Gu H Int Immunopharmacol; 2021 Oct; 99():107997. PubMed ID: 34315115 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA LINC-PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR-425-5p/PTCH1/SHH axis. Yuan Z; Xiu C; Liu D; Zhou G; Yang H; Pei R; Ding C; Cui X; Sun J; Song K J Cell Physiol; 2019 Dec; 234(12):23111-23122. PubMed ID: 31131448 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA LINC-PINT is inhibited in gastric cancer and predicts poor survival. Feng H; Zhang J; Shi Y; Wang L; Zhang C; Wu L J Cell Biochem; 2019 Jun; 120(6):9594-9600. PubMed ID: 30569513 [TBL] [Abstract][Full Text] [Related]
10. LINC-PINT alleviates lung cancer progression via sponging miR-543 and inducing PTEN. Wang S; Jiang W; Zhang X; Lu Z; Geng Q; Wang W; Li N; Cai X Cancer Med; 2020 Mar; 9(6):1999-2009. PubMed ID: 31981466 [TBL] [Abstract][Full Text] [Related]
11. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway. Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407 [TBL] [Abstract][Full Text] [Related]
12. LncRNA ILF3-AS1 promotes cell migration, invasion and EMT process in hepatocellular carcinoma via the miR-628-5p/MEIS2 axis to activate the Notch pathway. Yan G; Chang Z; Wang C; Gong Z; Xin H; Liu Z Dig Liver Dis; 2022 Jan; 54(1):125-135. PubMed ID: 34053876 [TBL] [Abstract][Full Text] [Related]
13. LncRNA Linc-PINT inhibits miR-523-3p to hamper retinoblastoma progression by upregulating Dickkopf-1 (DKK1). Zhou X; Wang Y; Li Q; Ma D; Nie A; Shen X Biochem Biophys Res Commun; 2020 Sep; 530(1):47-53. PubMed ID: 32828314 [TBL] [Abstract][Full Text] [Related]
14. LINC-PINT Suppresses the Aggressiveness of Thyroid Cancer by Downregulating miR-767-5p to Induce TET2 Expression. Jia M; Li Z; Pan M; Tao M; Wang J; Lu X Mol Ther Nucleic Acids; 2020 Dec; 22():319-328. PubMed ID: 33230437 [TBL] [Abstract][Full Text] [Related]
15. LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21. Liu W Cancer Biother Radiopharm; 2019 May; 34(4):258-263. PubMed ID: 31070482 [No Abstract] [Full Text] [Related]
16. Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2. Zhou Q; Guo J; Huang W; Yu X; Xu C; Long X Mol Oncol; 2020 Sep; 14(9):2231-2250. PubMed ID: 32335998 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p. Sun X; Huang T; Zhang C; Zhang S; Wang Y; Zhang Q; Liu Z Cell Cycle; 2019 Aug; 18(16):1908-1924. PubMed ID: 31213129 [No Abstract] [Full Text] [Related]
18. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis. Cheng L; Xing Z; Zhang P; Xu W Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530 [TBL] [Abstract][Full Text] [Related]
19. Bladder Cancer Progression Is Suppressed Through the Heart and Neural Crest Derivatives Expressed 2-Antisense RNA 1/microRNA-93-5p/Defective in Cullin Neddylation 1 Domain Containing 3 Axis. Wu X; Xu Q; Li T; Wei Y; Zeng R; Lin R; Xu L; Ye L; Liu Z Appl Biochem Biotechnol; 2023 Jul; 195(7):4116-4133. PubMed ID: 36656536 [TBL] [Abstract][Full Text] [Related]
20. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p. Han X; Liu J; Liu Y; Mou L; Li C Cancer Manag Res; 2021; 13():4393-4401. PubMed ID: 34103994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]